Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Collaborates with Axon on Cell-Manipulation Microfluidic Chip Platform


Microfluidics maker Fluidigm has signed a collaboration with Axon Instruments to develop a cell capture and manipulation microfluidics chip for drug discovery, the company said.

Under the agreement, Fluidigm, of South San Francisco, Calif., will use its flexible rubber microfluidics technology to design the chip to Axon''s specifications, and Axon will design an instrument platform for using the chips, which will be disposable. Axon will likely market the device and the chips, said Rodney Turner, Fluidigm''s vice president of business development.

The companies have conceptualized this microfluidics platform as a new tool for precisely handling and manipulating tiny amounts of eukaryotic cells. They expect the system to be used by researchers to study drug target function in a natural cellular environment.

"This is one of Axon''s strategic efforts to access the drug discovery space," said Turner. "The deal we have with them plays to their ambition and strategy in instrument development for high-throughput screening."

Fluidigm''s chips contain microscopic valves and pumps that can be activated through application of precise amounts of air pressure.

Turner said Fluidigm would be announcing another collaboration shortly.



The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.